Vimal Mehta, CEO, President, Secretary at BioXcel Therapeutics, Inc. (BTAI), bought 1,000 shares at $5.10 ($5K) on 2018-12-03, disclosed to the SEC on 2018-12-04.
Open-market purchase of $5k BTAI by CEO, President, Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.10 | 200 | $1K | 19.7% |
| 2 | $5.13 | 100 | $513 | 9.9% |
| 3 | $5.14 | 100 | $514 | 10.0% |
| 4 | $5.18 | 100 | $518 | 10.0% |
| 5 | $5.20 | 500 | $3K | 50.3% |
| Total | $5.17 avg | 1,000 |
| $5K |
| 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |